Automate Your Wheel Strategy on MDT
With Tiblio's Option Bot, you can configure your own wheel strategy including MDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MDT
- Rev/Share 26.1538
- Book/Share 37.6324
- PB 2.4325
- Debt/Equity 0.5938
- CurrentRatio 1.8491
- ROIC 0.0608
- MktCap 116722786000.0
- FreeCF/Share 4.0435
- PFCF 22.5116
- PE 25.052
- Debt/Assets 0.311
- DivYield 0.0308
- ROE 0.0962
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | MDT | Wolfe Research | Underperform | Peer Perform | -- | -- | June 30, 2025 |
| Initiation | MDT | Leerink Partners | -- | Outperform | -- | $110 | June 16, 2025 |
| Upgrade | MDT | Citigroup | Neutral | Buy | $92 | $107 | March 4, 2025 |
| Upgrade | MDT | RBC Capital Mkts | Sector Perform | Outperform | $98 | $105 | Oct. 10, 2024 |
| Reiterated | MDT | Oppenheimer | -- | Perform | $92 | $94 | Aug. 21, 2024 |
News
The Best High-Yield Healthcare Stock to Invest $1,000 in Right Now
Published: August 22, 2025 by: The Motley Fool
Sentiment: Neutral
I happily own stock in Medtronic (MDT -2.25%), one of the largest medical device makers in the world. Of late, the company is struggling through a rough patch that has Wall Street worried about the future.
Read More
Medtronic: Earnings Are Solid, New Board Additions Add Intrigue
Published: August 21, 2025 by: Seeking Alpha
Sentiment: Positive
Medtronic delivered solid earnings, with standout growth in Cardiovascular, but overall performance remains mixed due to weaker Neuroscience and MedSurg segments. Elliott Management's activist involvement and new board appointments could drive operational improvements and strategic divestitures, echoing past success at Cardinal Health. Valuation is attractive on a PEG basis, but I remain on hold, awaiting clear evidence of sustainable earnings momentum and operational execution.
Read More
These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings
Published: August 20, 2025 by: Benzinga
Sentiment: Positive
Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately.
Read More
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Medtronic: The Opportunity Gets Healthier for Income Investors
Published: August 19, 2025 by: MarketBeat
Sentiment: Positive
Medtronic's NYSE: MDT FQ1 results and guidance update did not spark a rally in the share price. Still, they did affirm a robust outlook that includes accelerating business growth, improving profitability, and reversing the stock price action.
Read More
Activist investor Elliott push spurs changes at Medtronic
Published: August 19, 2025 by: CNBC Television
Sentiment: Positive
Medical device maker Medtronic is making changes to its board after Elliott Investment Management became one of its largest shareholders. CNBC's David Faber breaks down the details.
Read More
Medtronic plc (MDT) Q1 2026 Earnings Call Transcript
Published: August 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Q1 2026 Earnings Conference Call August 19, 2025 8:00 AM ET Company Participants Geoffrey Straub Martha - Chairman of the Board & CEO Michael Marinaro - Executive VP & President of Medical Surgical Portfolio and Americas Que Thanh Dallara - Executive VP & President Diabetes Operating Unit Ryan Weispfenning - VP & Head of Investor Relations Thierry Pieton - Executive VP & CFO Conference Call Participants Anthony Charles Petrone - Mizuho Securities USA LLC, Research Division Joanne Karen Wuensch - Citigroup Inc. Exchange Research Joshua Thomas Jennings - TD Cowen, Research Division Lawrence H. Biegelsen - …
Read More
MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Neutral
Medtronic tops on Q1 earnings and revenues, raises full-year EPS outlook, but shares dip on board changes.
Read More
Medtronic (MDT) is a Top-Ranked Growth Stock: Should You Buy?
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Compared to Estimates, Medtronic (MDT) Q1 Earnings: A Look at Key Metrics
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Buy or Sell Medtronic Stock Now?
Published: August 18, 2025 by: Forbes
Sentiment: Neutral
Medtronic (NYSE:MDT) will report earnings on Tuesday, August 19, 2025. Over the last five years, the stock's next-day move following results has been highly unpredictable: it posted a positive one-day return in 50% of instances (median gain of 2.5%) and a negative one-day return in the other 50% (median loss of -3.8%).
Read More
Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Published: August 18, 2025 by: Benzinga
Sentiment: Neutral
Medtronic plc MDT will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19.
Read More
Insights Into Medtronic (MDT) Q1: Wall Street Projections for Key Metrics
Published: August 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2025.
Read More
MDT Stock Trades Cheaper Than Peers Ahead of Q1 Earnings: Time to Buy?
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
Medtronic trades at a notable discount to peers as Q1 earnings loom, but rising costs and tariffs could test its resilience.
Read More
Why Medtronic (MDT) is Poised to Beat Earnings Estimates Again
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Published: August 01, 2025 by: Benzinga
Sentiment: Positive
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Read More
Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
Published: July 21, 2025 by: PRNewsWire
Sentiment: Neutral
GALWAY, Ireland , July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by individuals aged 2 years and older, during pregnancy, as well as type 2 insulin-requiring diabetes. To gain CE Mark for this expansion of indications, published clinical data in 2–6-year-olds, pregnant women, and people living with type 2 diabetes was reviewed.
Read More
BofA Securities Top Q3 Stocks Picks Feature 4 Incredible Dividend Ideas
Published: July 08, 2025 by: 24/7 Wall Street
Sentiment: Positive
Dividend stocks are a favorite among investors for good reason.
Read More
BSX vs. MDT: Which MedSurg Stock Is the Better Investment Now?
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two prominent companies with a strong foothold in this space are Boston Scientific BSX and Medtronic MDT.
Read More
Why Is Medtronic (MDT) Up 6% Since Last Earnings Report?
Published: June 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Read More
6 Upcoming Dividend Increases
Published: June 19, 2025 by: Seeking Alpha
Sentiment: Positive
I focus on companies with consistent dividend growth, using a blend of the U.S. Dividend Champions list and NASDAQ data for my selections. This week's highlighted group averages a 5.9% dividend increase and a 19.5-year streak, but none outperformed the SCHD ETF over the past decade. While SCHD remains my benchmark for dividend growth and total return, I look for individual stocks that can deliver significant alpha over it.
Read More
Medtronic Announces Intent To Spin Diabetes Business
Published: June 09, 2025 by: Forbes
Sentiment: Positive
Deal OverviewOn May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business into a standalone entity (New Diabetes Company). This strategic move is designed to streamline Medtronic's portfolio, sharpen its focus on high-margin growth areas, and unlock shareholder value.
Read More
Medtronic plc (MDT) Bernstein's 41st Strategic Decisions Conference - (Transcript)
Published: May 29, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Bernstein's 41st Strategic Decisions Conference Call May 29, 2025 11:00 AM ET Company Participants Geoff Martha - Chairman and Chief Executive Officer Thierry Pieton - Executive Vice President and Chief Financial Officer Conference Call Participants Lee Hambright - Bernstein Lee Hambright All right. Very good.
Read More
ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now?
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
Intuitive Surgical or Medtronic -- who leads the future of robotic surgery? Here's a comparative analysis to help you make a smart choice for 2025.
Read More
No Rolex For Me - I'm Buying Dividends That Pay For Life
Published: May 26, 2025 by: Seeking Alpha
Sentiment: Positive
I love luxury watches, but buying more to "earn" access to rarer models made me realize how easy it is to waste capital chasing ego-driven goals. Unlike watches, dividend growth stocks offer reliable long-term returns. A $10K McDonald's investment in 2004 would've yielded over $22K in dividends alone. History shows that strong-yielding dividend stocks, especially those in the second quintile, have consistently outperformed the market with lower risk.
Read More
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
Published: May 25, 2025 by: Seeking Alpha
Sentiment: Positive
Upgrading Medtronic to 'Strong Buy' with a $104 fair value, driven by the diabetes business spin-off catalyst. Divesting diabetes enables Medtronic to focus on core cardiac and surgical markets, improving operating margins and capital allocation. Recent results show robust cardiovascular growth and strong shareholder returns, with continued buybacks expected post-spin-off.
Read More
'WIN-WIN': Medtronic CEO explains the reason for diabetes biz spin
Published: May 22, 2025 by: Fox Business
Sentiment: Positive
Medtronic chairman and CEO Geoff Martha explains why the company is separating the diabetes business on 'The Claman Countdown.' #foxbusiness #usnews #economy #investing #diabetes #health #markets
Read More
Medtronic plc (MDT) Q4 2025 Earnings Call Transcript
Published: May 21, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Q4 2025 Earnings Conference Call May 21, 2025 8:00 AM ET Company Participants Ryan Weispfenning - VP and Head of IR Geoff Martha - Chairman and CEO Que Dallara - EVP & President, Diabetes Thierry Pieton - CFO Sean Salmon - EVP and President of Cardiovascular Portfolio Brett Wall - EVP and President of Neuroscience Portfolio Conference Call Participants Travis Steed - Bank of America Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore Joanne Weunsch - Citi Matt Taylor - Jefferies Matt Miksic - Barclays Danielle Antalffy - UBS Shagun Singh …
Read More
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Medtronic to split off its fast-growing diabetes business to unlock its value
Published: May 21, 2025 by: Market Watch
Sentiment: Positive
The new diabetes company will be predominantly business-to-consumer, while Medtronic's model was more business-to-business.
Read More
About Medtronic plc (MDT)
- IPO Date 1973-05-02
- Website https://www.medtronic.com
- Industry Medical - Devices
- CEO Geoffrey Straub Martha
- Employees 95000